Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep Parasternal vs Erector Spinae Block in Pediatric Cardiac Surgery
NCT06873906Phase 3Not yet recruiting
- Sponsor
- Ain Shams University
- Start
- Mar 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of bupivacaine hydrochloride 0.75% injection in postoperative pain (3 arms), sponsored by Ain Shams University. Primary endpoint: Time of the first request for postoperative analgesics at 24 hours. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06873906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06873906.